Ceiling Price Lookup

  1. To look up ceiling prices, click Pricing in the “What Would You Like to Do?” section or click the Pricing tab on the menu bar of the Closed340B OPAIS home page

    Pricing tab of 340B OPAIS homepage highlighted

  2. Upon selecting the Pricing function, the system will prompt you to log in and authenticate again to gain access to the Pricing data.

  3. Upon a successful login, the system displays the ClosedCeiling Price page. This table can be sorted and filtered to make the data displayed more manageable. For more information, refer to Data Tables.

    CE Product List

Ceiling Price Lookup Controls
Control Description
Only Favorites

  • When this checkbox is selected, the page displays only the National Drug Codes (NDCs) you have defined as favorites.

  • When this checkbox is not selected, the page displays the default ceiling price search results.
Edit Favorites Clicking this button displays a pop-up window to let you enter a list of favorite NDCs.
National Drug Code Select a link in the National Drug Codes column to view the Product Detail page for that ClosedNDC.
Ceiling Price Calculated by subtracting the unit rebate amount (ClosedURA) from the average manufacturer price (AMP) for the smallest unit of measure of each covered outpatient drug (as identified by the product’s 11-digit NDC).
Package Adjusted Price Calculated by multiplying the Ceiling Price amount by the drug’s Package Size (ClosedPS), the number of billing units in the labeled quantity, and by the Case Pack Size (ClosedCSP), the number of salable units in the shipping container.
Flag

The asterisks in the Flag column indicate that HRSA had only one source of information for determining the 340B ceiling price. The full meaning for the asterisks is shown at the bottom of the page:

(*) The 340B ceiling price for this product was calculated by HRSA solely based on ClosedCMS data. The Manufacturer did not submit 340B pricing data to HRSA for ceiling price comparison. HRSA publishes the 340B ceiling price without comparing it to the manufacturer’s data in situations where the manufacturer has not uploaded their quarterly pricing data to the 340B OPAIS Pricing Application or has missed the submission period.

(**) The 340B ceiling price for this product was calculated by HRSA solely based on using only data submitted by the manufacturer. No CMS pricing data was available for ceiling price comparison. HRSA publishes the 340B ceiling price without comparing it with the AMP and URA data points received from CMS in situations where the manufacturer does not participate in the Medicaid Drug Rebate Program and CMS has no quarterly pricing data to report for the specified product

(***) The 340B ceiling price was adjusted by HRSA after review/adjudication of all available data. HRSA publishes the 340B ceiling price after the data points were adjusted by HRSA during review/adjudication.

(*****) The product is a New Drug Price Estimate. HRSA publishes the 340B ceiling price for the product that has been marked as a New Drug Price Estimate.

(c) – This is the corrected price for this quarter

Subtopics